Analyst Ratings For Cara Therapeutics
Analyst Ratings For Cara Therapeutics
cara therapeutics的分析師評級
Cara Therapeutics (NASDAQ:CARA) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在過去的三個月裏，Cara Therapeutics（納斯達克：CARA）已被5位分析師進行了分析，顯示出從看好到看淡的多種觀點。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近評級的精簡視圖，顯示了過去30天的不同情緒，並將其與前幾個月進行比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $4.72, a high estimate of $5.00, and a low estimate of $3.60. This current average has increased by 4.19% from the previous average price target of $4.53.
12個月價格目標的分析師洞察被揭示出來，呈現出平均目標爲4.72美元，最高估價爲5.00美元，最低估價爲3.60美元。這個當前的平均目標從上次平均價格目標4.53美元上增長了4.19%。
Exploring Analyst Ratings: An In-Depth Overview
分析師評級:深入了解
The perception of Cara Therapeutics by financial experts...
通過最近的分析師...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。